Figure 4From: Development and evaluation of a novel radioiodinated vesamicol analog as a sigma receptor imaging agent Comparison of tumor/tissue uptake ratio (mean ± SD) of (+)-[125 I]IV-OH. At 1-h post-injection under no-carrier-added condition and under co-injection of haloperidol, SA4503, or (+)-p IV. Significance was determined using one-way ANOVA followed by Dunnett's post hoc test (p < 0.01 vs. control (asterisk)).Back to article page